IART
Integra Lifesciences Holdings·NASDAQ
--
--(--)
--
--(--)
IART fundamentals
Integra Lifesciences Holdings (IART) Revenue Breakdown: Q3 2025 Business & Regional Performance
Integra Lifesciences Holdings (IART) reported total revenue of 402.06M USD in Q3 2025, with its core business segment Specialty Surgical Solutions contributing 72.77%. Regionally, United States remained the largest market, accounting for 73.58% of total revenue. Explore Integra Lifesciences Holdings's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Integra Lifesciences Holdings (IART) reported total revenue of 402.06M USD in Q3 2025, with its core business segment Specialty Surgical Solutions contributing 72.77%. Regionally, United States remained the largest market, accounting for 73.58% of total revenue. Explore Integra Lifesciences Holdings's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Integra Lifesciences Holdings’s earnings call?What is the market's earnings forecast for Integra Lifesciences Holdings next quarter?What factors drove the changes in Integra Lifesciences Holdings's revenue and profit?Did Integra Lifesciences Holdings beat or miss consensus estimates last quarter?What is Integra Lifesciences Holdings's latest dividend and current dividend yield?What is Integra Lifesciences Holdings's gross profit margin?What is the revenue and EPS growth rate for Integra Lifesciences Holdings year over year?What does Integra Lifesciences Holdings do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
